Investigational glutamatergic modulator
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational glutamatergic modulator, covering 2024-07-16 to 2024-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial [Phase 2]